Wolf Theiss advises Royal DSM on acquisition of ERBER Group

Vienna, 15 June 2020 – Wolf Theiss as lead counsel is advising Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living listed on Euronext Amsterdam, on the acquisition of ERBER Group. Completion of the transaction – which excludes two smaller units in the Erber Group – remains subject to customary conditions.

DSM Koninklijke DSM N.V. is a Dutch multinational corporation active in the fields of health, nutrition and materials. Headquartered in Heerlen, it employs around 23,000 people in approximately 50 countries. DSM provides nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.

Erber Group’s specialty animal nutrition and health businesses, Biomin and Romer Labs, specialize primarily in mycotoxin risk management, gut health performance management, and food and feed safety diagnostic solutions, expanding DSM’s range of higher value-add specialty solutions. Romer Labs also complements DSM’s human nutrition and health offering to food industry customers.

The Wolf Theiss team advising DSM lead is led by corporate/M&A partner Florian Kusznier, who is primarily supported by a core team of Zeno Grabmayr, Senior Associate, Partners Markus Bruckmüller (corporate/M&A), Günter Bauer (competition), Kurt Retter (public law regulatory) and Karl Binder (real estate) and Associates Martina Hiebl, Lukas Slameczka and Simona Shpilsky (all corporate/M&A). The team further includes specialists in Austria and CEE across various practice areas.

Read the full text

Download PDF